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Aims: Donation after circulatory death (DCD) could improve cardiac graft availability,
which is currently insufficient to meet transplant demand. However, DCD organs undergo
an inevitable period of warm ischemia and most cardioprotective approaches can only
be applied at reperfusion (procurement) for ethical reasons. We investigated whether
modifying physical conditions at reperfusion, using four different strategies, effectively
improves hemodynamic recovery after warm ischemia.
Methods and Results: Isolated hearts of male Wistar rats were perfused in
working-mode for 20min, subjected to 27min global ischemia (37◦C), and 60min
reperfusion (n = 43). Mild hypothermia (30◦C, 10min), mechanical postconditioning
(MPC; 2x 30 s reperfusion/30 s ischemia), hypoxia (no O2, 2min), or low pH (pH
6.8–7.4, 3min) was applied at reperfusion and compared with controls (i.e., no strategy).
After 60min reperfusion, recovery of left ventricular work (developed pressure∗heart
rate; expressed as percent of pre-ischemic value) was significantly greater for mild
hypothermia (62 ± 7%), MPC (65 ± 8%) and hypoxia (61 ± 11%; p < 0.05 for all), but
not for low pH (45 ± 13%), vs. controls (44 ± 7%). Increased hemodynamic recovery
was associated with greater oxygen consumption (mild hypothermia, MPC) and coronary
perfusion (mild hypothermia, MPC, hypoxia), and with reduced markers of necrosis (mild
hypothermia, MPC, hypoxia) and mitochondrial damage (mild hypothermia, hypoxia).
Conclusions: Brief modifications in physical conditions at reperfusion, such
as hypothermia, mechanical postconditioning, and hypoxia, improve post-ischemic
hemodynamic function in our model of DCD. Cardioprotective reperfusion strategies
applied at graft procurement could improve DCD graft recovery and limit further injury;
however, optimal clinical approaches remain to be characterized.
Keywords: acidic reperfusion, cardioprotection, donation after circulatory death, heart transplantation, hypoxia,
ischemia reperfusion injury, mechanical postconditioning, mild hypothermia
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INTRODUCTION
Unfortunately, insufficient supply of cardiac grafts has become
an obstacle in heart transplantation. Importantly, heart
transplantation remains the gold standard treatment for
improving quality of life and survival in severe cases of heart
failure, one of the leading causes of morbidity and mortality in
western countries. In Europe, 6438 patients were registered on
waiting lists for heart transplantation in 2014 and 567 patients
(∼8.8%) (Council of EuropeMatesanz, 2015) died while awaiting
a donor heart. Increasing organ availability with donation after
circulatory death (DCD) (Longnus et al., 2014), in addition to
conventional donation after brain death, is one promising option
to overcome the organ shortage.
Although the heart transplantation was first performed with
DCD (Barnard, 1967), DCD has generally not been considered
for cardiac donation due to concerns about irreversible cardiac
injury arising from warm ischemia. Unlike donation after brain
death, DCD organs undergo an inevitable period of warm,
unprotected, global ischemia between circulatory arrest and
graft procurement. Recent reports of successful DCD heart
transplantations in Australia (Dhital et al., 2015) and in the UK
(Leprince et al., 2016; Macdonald et al., 2016; Page et al., 2016)
attest to the feasibility of DCD heart transplantation and the
ability of hearts to withstand a limited period of warm ischemia
(20–30min) (Iyer et al., 2014). Nonetheless, in order to make
DCD heart transplantation a routine approach, clinical strategies
that limit reperfusion injury and optimize post-transplant graft
function remain to be characterized.
With DCD, organ protection strategies applied at the time
of reperfusion hold particular promise, given that protective
treatment options are limited before and during ischemia
for ethical reasons. As reperfusion injury contributes to up
to 50% total myocardial damage (Yellon and Hausenloy,
2007; Hausenloy and Yellon, 2013), approaches to limit this
injury could provide an important clinical impact. Reperfusion
injury is mediated, in the immediate minutes after ischemia,
by increased calcium overload, rapid correction of pH,
and mitochondrial reenergization, which causes a burst in
reactive oxygen species production (Yellon and Hausenloy,
2007). These processes converge to induce cardiomyocyte
hypercontracture and/or to promote the opening of the
mitochondrial permeability transition pore (mPTP), which may
ultimately lead to cardiomyocyte death. Inhibiting or slowing
these processes may therefore improve graft recovery.
The conditions present in DCD heart transplantation may be
particularly amenable to cardioprotective reperfusion strategies.
Identification of robust cardioprotective reperfusion strategies
has been the subject of intense research activity for several
years, but promising pre-clinical approaches have seldom
provided convincing cardioprotection in patients with ST-
segment elevation myocardial infarction (STEMI) (Downey
and Cohen, 2009; Lloyd-Jones, 2010; Kloner, 2013; Bulluck
et al., 2016). This might be explained by interfering effects of
co-morbidities and/or concomitant therapies (Hausenloy and
Yellon, 2004; Bell and Yellon, 2012), delayed application of
cardioprotective strategies (Roubille et al., 2014) and/or too long
or too short ischemia (Barsukevich et al., 2015). However, with
DCD cardiac grafts, donors will be subject to donor selection,
and thus patients will generally be young and healthy, thereby
limiting possible negative effects associated with comorbidities
and medical therapies. Furthermore, timely application of
strategies should be achievable as the duration of ischemia will
be limited in DCD settings.
Several reperfusion strategies have the potential to improve
post-ischemic hemodynamic function in the setting of DCD. For
example, hypoxic and acidic reperfusion would be expected to
slow the production of reactive oxygen species and the correction
of intracellular pH, respectively; thereby reducing reperfusion
injury (Serviddio et al., 2005; Angelos et al., 2006; Inserte et al.,
2008; Duan et al., 2011). It is also well recognized that decreasing
temperature during ischemia and/or reperfusion leads to a better
recovery (Mochizuki et al., 2012; Stadelmann et al., 2013). Finally,
mechanical postconditioning (MPC), brief, intermittent periods
of ischemia applied at the onset of reperfusion, has also been
demonstrated as cardioprotective (Ferrera et al., 2015; Bartkevics
et al., 2016). However, the majority of studies performed to
evaluate reperfusion strategies have used models of regional
ischemia induced by temporary occlusion of a coronary artery,
with analysis of the infarcted area as the typical endpoint
(Rossello and Yellon, 2016), and the contractile function of the
heart is rarely assessed. As such, findings from these studies
cannot be easily extrapolated to situations with clinically relevant
DCD conditions, including high pre-ischemic fatty acids levels,
warm, global ischemia and hemodynamic evaluation.
Therefore, we hypothesized that reperfusion strategies,
applied immediately following ischemia, such as mild
hypothermia, mechanical postconditioning (MPC), hypoxia
and mildly acidic reperfusion, could improve hemodynamic
recovery after warm, global ischemia in our isolated working rat
heart model of DCD.
MATERIALS AND METHODS
Experimental Design
The objective of this experimental study was to test the hypothesis
that the application of reperfusion strategies effectively improves
post-ischemic hemodynamic function in an isolated rat heart
model of DCD using a prospective, 5-arm parallel, randomized
controlled design.
Materials
Bovine serum albumin (fatty-acid free) and palmitate were
obtained from Sigma–Aldrich (Buchs, Switzerland). All other
chemicals were acquired fromMerck (Darmstadt, Germany).
Ethics Statement
All experimental procedures were performed in compliance with
the European Convention for Animal Care and approved by
the Swiss animal welfare authorities and state veterinary office
(Ethics Committee for Animal Experimentation (ECAE), Berne,
Switzerland). Surgery was performed under anesthesia and all
efforts were made to minimize animal suffering.
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Isolated Heart Preparation
Isolated, working rat hearts were prepared as previously
described (Dornbierer et al., 2012). Adult male Wistar rats
(n = 43; 400 ± 24 g; Janvier labs, Le Genest-Saint-Isle,
France), housed under standard conditions with unlimited
access to food (standard laboratory diet ad libitum) and
water, were anesthetized intraperitoneally using 100mg/kg of
ketamine (Narketan R©, Vetoquinol AG, Berne, Switzerland)
and 10mg/kg of xylazine (Xylapan R©, Vetoquinol AG, Berne,
Switzerland). Ketamine and xylazine may interfere with the
sympathetic nervous system (Juang et al., 1980; Svorc et al.,
2013), which could potentially play a confounding role in
our model of ischemia and reperfusion injury; however, this
anesthetic protocol has been chosen over the alternatives of
pentobarbital and inhalation anesthetics, which are recognized to
have cardiorespiratory depressant (Segel and Rendig, 1986) and
ischemic preconditioning effects, respectively (Stowe and Kevin,
2004).
After anesthesia and as soon as the pedal reflex had
disappeared, the thoracic cage was opened and hearts were
excised, weighed and immediately placed in ice-cold PBS. Hearts
were then perfused in a retrograde manner, via the cannulated
aorta, with a modified Krebs-Henseleit bicarbonate (KHB)
buffer containing: 118mM NaCl, 4.7mM KCl, 1.2mM KH2PO4,
1.2mMMgSO4·7H2O, 1.25mM CaCl2·7H2O, 25mM NaHCO3,
and 11mM glucose, at a constant pressure of 60 mmHg. Once
the left atrium was cannulated, hearts were switched to working
mode perfusion and a micro-tip pressure catheter (Millar,
Houston, USA or Scisense, Transonic, London, Canada) was
inserted into the left ventricle prior to starting the experimental
protocol.
Experimental Protocol
Heart perfusion was designed to simulate DCD conditions as
shown in Figure 1. A period of warm ischemia of 27min has,
in our hands, provided a reproducible and appropriate balance
of post-ischemic haemodynamic recovery, permitting the
evaluation of potentially cardioprotective reperfusion strategies.
With shorter ischemic times, the level of recovery appeared too
high to allow the quantification of a possible benefit, whereas
with longer ischemic times, the damage was too severe, possibly
precluding improvement. This is also in agreement with warm
ischemic times reported for human DCD heart transplantations
performed in Australia and the UK, which range from 11 to
24min (Dhital et al., 2015; Page et al., 2016).
First, hearts underwent a baseline period in working mode
for 20min with KHB supplemented with 1.2mM palmitate and
3% albumin. Hearts were excluded from the study if the mean
left ventricular work (developed pressure-heart rate product)
during baseline was below 23,000 mmHg∗beats∗min−1. During
working-mode baseline perfusion, afterload column height was
set to 80 mmHg.
Following baseline perfusion, hearts were subjected to 27min
of global, no-flow, normothermic (37◦C) ischemia: preload-
and afterload-perfusate lines were clamped and the hearts were
immersed in a tissue bath at 37◦C containing energy-substrate–
free KHB bubbled with 95% N2/5% CO2.
Reperfusion was initiated in the unloaded mode at a
constant pressure of 60mmHg for 10min. Following unloaded
reperfusion, hearts were switched to working mode for the
remainder of the 60min reperfusion. During working-mode
reperfusion, mean afterload pressure was maintained at 60
mmHg with the aid of a peristaltic pump. Reperfusion was
limited to 60min as this duration is sufficient for determination
of early hemodynamic recovery (Ferrera et al., 2009).
Throughout the aerobic perfusion periods, preload pressure
was set at 11.5 mmHg, and perfusate buffers were maintained
at 37◦C and oxygenated with 95% O2/5% CO2. Samples of
circulating buffer and coronary eﬄuent were taken at several
time points: at 0, 10, and 20min during the baseline, pre-
ischemic period, and at 0, 3, 5, 10, 20, 40, and 60min during
the reperfusion period (Figure 1). Circulating buffer samples
were obtained immediately upstream of the heart with the aid
of injection ports that allow access to perfusate lines. Coronary
eﬄuent samples were collected from the buffer that drips off the
heart following its ejection from the right ventricle into the cut
pulmonary artery.
Hearts from rats were randomly assigned (i.e., in an
alternating fashion) before anesthesia to one of four reperfusion-
strategy groups, or to the control group (no strategy applied).
Controlled reperfusion strategies were applied immediately
following ischemia, at the onset of reperfusion, and included:
i) mild hypothermia, for which temperature of the perfusate
was maintained at 30◦C for 10min followed by progressive
rewarming to reach 37◦C after 15min reperfusion; ii)
mechanical postconditioning (MPC), consisting of two cycles
of 30 s reperfusion and 30 s ischemia, starting immediately at
reperfusion; iii) hypoxia (<10% O2) for 2min; and iv) acidic
reperfusion at pH 6.8 with stepwise increments (0.2 pH units per
min) to reach a pH of 7.4 after 3min reperfusion.
The precise protocols used for reperfusion strategies in this
study were chosen based on promising approaches reported in
various models of cardiac ischemia-reperfusion injury. Although
mild hypothermia during ischemia (Stadelmann et al., 2013) or
for an extended period during reperfusion (Mochizuki et al.,
2012) has been demonstrated to protect the heart from IR injury,
its effects when applied only briefly at the time of reperfusion,
have not previously been investigated. Thus, we perfused hearts
at 30◦C immediately upon reperfusion for 10min. Identical MPC
cycle conditions have been demonstrated to be cardioprotective
using similar models of global ischemia (Ferrera et al., 2015;
Bartkevics et al., 2016), and were therefore tested with the current
DCD model. In addition, a small number of studies have tested
hypoxic postconditioning with varying models and reperfusion
conditions: either 3min at 150mmHg pO2 (Serviddio et al., 2005)
or 5min at 2% O2 (Angelos et al., 2006) in isolated, perfused
hearts, or 5min reoxygenation and 5min rehypoxia in neonatal
rat cardiomyocytes (Sun et al., 2005). Therefore, we decided to
test the effects of no O2 for 2min in our model for its clinical
practicality. Several acidic reperfusion strategies have also been
tested, using with ranges of pH from 6.6 to 6.8 (Inserte et al., 2008,
2011; Duan et al., 2011; Penna et al., 2013; White et al., 2016); we
decided to use a mildly acidic strategy, starting at pH 6.8 and then
increasing with stepwise increments of 0.2 pH units per min to
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FIGURE 1 | Perfusion protocol. Hearts underwent 20min of baseline working-mode perfusion, followed by 27min of warm global ischemia and 60min of
reperfusion. Hearts underwent reperfusion in the unloaded mode for the first 10min, and were then switched to the loaded mode for the remaining 50min.
Cardioprotective reperfusion strategies, applied at the onset of reperfusion, included: mild hypothermia, mechanical postconditioning, hypoxia, and mild acid. Sample
time points for preload and coronary effluent buffer are indicated in the timeline at the top of the figure.
reach 7.4 after 3min, as preliminary tests with lower pH levels
and rapid normalization led to worse recovery compared with
controls (data not shown).
Data Collection
Intra-ventricular pressures and buffer flow (Transonic
Systems Inc., Ithaca, NY, USA) in preload and afterload
lines were continuously recorded using a PowerLab data
acquisition system (ADInstruments, Spechbach, Germany).
The following hemodynamic parameters were assessed:
heart rate (beats∗min−1), developed pressure (mmHg), left
ventricular (LV) work (developed pressure-heart rate product;
mmHg∗beats∗min−1), coronary flow (mL∗min−1), cardiac
output (mL∗min−1), contraction and relaxation rates (dP/dtmax
and dP/dtmin; mmHg
∗s−1).
Buffer samples were used to assess metabolic parameters
(oxygen consumption, lactate accumulation and cytochrome
c (cyt c) release), as well as the release of necrosis markers
[lactate dehydrogenase (LDH) and troponin-T (TnT)]. Oxygen
consumption was determined using the Cobas b 123 blood-gas
analyzer (Roche, Basel, Switzerland). Lactate accumulation
was determined using a lactate assay (Sigma-Aldrich,
Buchs, Switzerland) and cyt c release by an enzyme-linked
immunosorbent assay (ELISA; Abcam, Cambridge, UK).
LDH release was assessed using the Roche MODULAR
P800 analyzer (Roche Diagnostics Corp, Indianapolis, USA),
while TnT release was assessed using the Roche MODULAR
E170 analyzer (Roche, Basel, Switzerland) and an electro-
chemiluminescence immunoassay analyzer (Roche, Basel,
Switzerland). All parameters were assessed at an early time point,
10min reperfusion, as it may provide key information given that
reperfusion injury is believed to occur in the first minutes of
reperfusion, that all of our reperfusion treatments are finished
at this time, and that we have previously shown that multiple
parameters at this timepoint provide indications of subsequent
hemodynamic recovery (Dornbierer et al., 2012; Sourdon et al.,
2013).
Data Analysis
Recovery was calculated as the 60-min reperfusion time point
value expressed as a percentage of the mean baseline (pre-
ischemic) value.
Lactate accumulation was calculated as:
(CT2 ∗ VT2 − CT1 ∗ VT1 )
HW
.
C = concentration; HW = heart weight; T = time point; V =
buffer volume
Necrosis factor and cyt c release were calculated as:
CF ∗ (CCE − CPL)
HW
C = concentration; CE= coronary eﬄuent; CF = coronary flow;
HW = heart weight; PL= preload
Oxygen consumption was calculated as:
CF ∗ (PPL − PCE)
HW
P = partial pressure of O2; CE = coronary eﬄuent; CF =
coronary flow; HW = heart weight; PL= preload
Unless stated otherwise, values are reported as mean ± SD.
Data analysis was performed with Stata (version 12.0, StataCorp,
College Station, Texas). Differences between experimental
groups for body weight, heart weight, hemodynamic
measurements, lactate accumulation, and the release of cyt
c and necrosis markers were evaluated using a linear mixed
model analysis with the control group (no reperfusion strategy
applied) as the reference. Mixed model analysis was also
used to investigate differences between experimental groups
for measurements of hemodynamic parameters and oxygen
consumption at 20, 40, and 60min reperfusion, with the
corresponding baseline measurement as a covariate. We
repeated the analysis for measurements at 40 and 60min
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reperfusion as a sensitivity analysis, to ensure that the
assumption of strict linearity for the three measurements
20, 40 and 60min reperfusion was acceptable. For lactate release,
differences between experimental groups were also analyzed
with mixed models for 3–5, 3–10, and 5–10min reperfusion,
using the corresponding baseline measurement as a covariate.
Model fit was assessed by inspecting the residuals. Pairwise
comparisons were performed with t-tests for percent recovery
of hemodynamic parameters and oxygen consumption. All
p-values were two sided, adjusted for multiple comparisons
(modified sequential rejective Bonferroni procedure, Holland
and Copenhaver, 1987) and reported after correction. Corrected
p-values were considered statistically significant if p < 0.05.
RESULTS
A total of 43 hearts was included in this study.
Baseline Characteristics
Rat body and heart weights, and all parameters measured during
the baseline perfusion are presented in Table 1. Compared to the
control group, no difference for any parameter was measured
in the mild hypothermic or acidic groups. However, slight
differences, compared to controls, were observed for the MPC
group (lower heart rate and higher cyt c release) and as well as for
the hypoxic group (higher body weight and lower LV work, heart
rate, and lactate release).
Post-Ischemic Recovery
As mentioned above, mixed model analyses were used to
investigate differences between experimental groups for the
measurements at 20, 40, and 60min reperfusion or for only 40
and 60 min reperfusion as a sensitivity analysis (corresponding
baseline measurements were included as covariates). Findings of
the two analyses were almost identical, except that in the analysis
with the three time points, mild hypothermia coronary flow was
found to be significantly different from controls (not significant
with the two time point analysis), and two significant differences
with the two time point analysis were no longer significant with
the three time point analysis (coronary flow for MPC vs. control
and oxygen consumption for mild hypothermia vs. control). The
three time-point analysis was thus considered acceptable and
used for the analysis of this study.
Hemodynamic Parameters
Hemodynamic parameters measured during reperfusion are
presented as both absolute values and percentages of pre-
ischemic values in Figure 2. Post-ischemic hemodynamic
recovery was improved with mild hypothermia, MPC and
hypoxia, but not different with acidic reperfusion, compared to
controls (Figure 2). More specifically, LV work and contraction
rates (dP/dtmax) were significantly higher withmild hypothermia,
MPC and hypoxia (p < 0.05), while significantly higher
developed pressure was measured for mild hypothermia and
hypoxia (p < 0.05). Furthermore, relaxation rates (dP/dtmin)
were significantly higher with MPC and hypoxia (p < 0.05).
Cardiac output was significantly higher for mild hypothermia
and MPC (p < 0.05) compared to controls. In addition, coronary
flow was significantly higher at the beginning (i.e., 5 and 10min)
of reperfusion in the MPC and hypoxia groups compared with
controls (p < 0.05), and at the end of reperfusion for mild
hypothermia vs. control (p < 0.05). Finally, significantly higher
heart rates were measured with mild hypothermia and MPC
compared to controls (data not shown).
Metabolic Parameters
Significantly higher oxygen consumption was measured at the
beginning of reperfusion with MPC (3, 5, and 10min) and with
acidic (10min) groups compared to controls (p < 0.05), and at
the end of reperfusion with mild hypothermia and MPC groups
vs. controls (Figure 3A).
Cyt c release, a marker of mitochondrial integrity, tended to be
lower in mild hypothermia and HY groups at 10min reperfusion
compared to control (p= NS; Figure 3B).
During reperfusion, we measured higher lactate accumulation
between 3 and 5min reperfusion in hypoxia vs. control (p< 0.05;
Figure 3C), at 10min in MPC and hypoxia, and at 60 min in
hypoxia compared to control (p < 0.05 for all).
Markers of Cell Death
LDH and TnT were measured as markers of cell death (Figure 4).
LDH release was significantly decreased at 10min reperfusion
for mild hypothermia and at 60min reperfusion for MPC and
hypoxia compared to controls (p < 0.05 for all). We also
measured a higher TnT release at 10min reperfusion in the MPC
group vs. controls (p < 0.05).
DISCUSSION
We report that short, controlled reperfusion strategies, applied
immediately following ischemia, effectively improve cardiac
hemodynamic recovery following global, normothermic
ischemia in our isolated working rat heart model of DCD. Hearts
subjected to mild hypothermia, mechanical postconditioning
(MPC), or hypoxia at reperfusion showed a significantly higher
post-ischemic hemodynamic recovery compared to controls (i.e.,
no strategy applied), but acidic reperfusion provided no benefit.
Assessment of metabolic and necrosis parameters support
the concept that differing, and potentially complementary,
mechanisms underlie the improvements associated with these
early reperfusion cardioprotective strategies.
To our knowledge, this is the first report that mild
hypothermia (30◦C), when applied only at the onset of
reperfusion for a brief period (10min), improves post-ischemic
heart function. We demonstrate that this reperfusion strategy
significantly improved recovery of LV work, developed pressure,
heart rate, contraction rate and cardiac output compared
with controls. This was associated with reduced LDH release,
indicating less necrosis, and higher coronary flow, suggesting
improved endothelial function, as well as increased oxygen
consumption and a tendency for less cyt c release, which together
imply a better metabolic recovery. It has previously been reported
that mild hypothermia can improve heart recovery when applied
during ischemia (Stadelmann et al., 2013), during ischemia and
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TABLE 1 | Baseline characteristics.
CT MH MPC HY PH
Number of hearts (n) 10 8 9 8 8
BW (g) 387± 25 405± 25 395±21 414± 31‡ 400±12
HW (g) 1.95± 0.18 2.05± 0.17 1.96±0.27 2.00± 0.26 1.90±0.15
LV work (mmHg*beats*min−1) 33,730± 4368 33,168± 1367 33,636±3571 29,689± 4534‡ 32,736±3223
HR (beats*min−1) 285± 37 263± 19 256±15† 258± 16‡ 278±18
DP (mmHg) 120± 14 126± 8 132±14 115± 16 118±9
dP/dtmin (mmHg*s
−1) −4077± 713 −4085± 340 −4150±567 −3963± 986 −3955±604
dP/dtmax (mmHg*s
−1) 3901± 543 4033± 352 4229±600 3394± 666 3881±447
CO (ml*min−1 ) 50± 5 50± 5 51±8 50± 7 49±8
CF (ml*min−1 ) 30± 3 29± 2 31±4 28± 3 30±3
Oxygen consumption (mmHg*mL*min−1*g wet−1 ) 5174± 612 4835± 512 5402±761 5028± 604 5401±893
Cyt c release (ng*min−1*g wet−1 ) 2± 2 5± 4 7±4† 3± 3 3±3
Lactate accumulation (µmol*g wet−1) 9± 4 9± 3 7±4 4± 3‡ 7±5
LDH release (U*min−1*g wet−1 ) 147± 171 81± 123 93±108 59± 62 28±39
TnT release (ng*min−1*g wet−1) 9± 7 9± 7 6±6 4± 3 6±6
BW, body weight; CF, coronary flow; CO, cardiac output; CT, control; cyt c release, cytochrome c release; DP, developed pressure; dP/dtmin, minimum first derivative of LV pressure;
dP/dtmax , maximum first derivative of LV pressure; HR, heart rate; HW, heart weight; HY, hypoxia; LDH release, lactate dehydrogenase release; LV Work, left-ventricular work (HR-DP
product); MH, mild hypothermia; MPC, mechanical postconditioning; PH, acidic; TnT release, Troponin T release. Data are expressed as mean ± SD.
†
MPC vs. control, p < 0.05;
‡
HY
vs. control, p < 0.05.
reperfusion (Shao et al., 2007, 2013), or when applied during
reperfusion if prolonged to 60 (Tolboom et al., 2016) or 180
(Mochizuki et al., 2012) min. Pro-survival kinases [protein
kinase C, protein kinase B (Akt)], endothelial nitric oxide
synthase (eNOS) and nitric oxide (NO), in addition to energy
preservation, have been reported to underlie some benefits
provided by mild hypothermia (Tissier et al., 2012). Although
intracellular signaling mechanisms were not explored in the
current study, our findings of greater post-ischemic coronary
flow and potentially improved endothelial function are consistent
with increased Akt and eNOS activities and elevated NO levels
reported previously (Shao et al., 2007; Mochizuki et al., 2012).
We also demonstrate that MPC is effective in improving post-
ischemic recovery of several parameters. Hemodynamic
parameters, including left ventricular work, heart rate,
contraction rate, relaxation rate, coronary flow and cardiac
output, were significantly greater than those for control
hearts during reperfusion, which is consistent with previous
reports in similar, working (loaded) heart models (Lauzier
et al., 2007; Bartkevics et al., 2016). Interestingly, MPC may
also promote glucose metabolism (Correa et al., 2008) and
its protective effects appear to depend on energy substrate
availability (Bartkevics et al., 2016). More specifically, we
previously found that the effect of MPC was dependent on
the circulating energy substrate levels at reperfusion; MPC
improved post-ischemic hemodynamic recovery in hearts
reperfused with fatty acids and glucose, but not in hearts
reperfused with glucose only (Bartkevics et al., 2016). This
effect is consistent with the requirement for MPC-induced
increases in glucose metabolism for its cardioprotective effects
(Correa et al., 2008); as in hearts reperfused with glucose only,
glucose metabolism may already be maximal, and can therefore
not be increased by MPC. Interestingly, in the present study,
MPC also improved hemodynamic recovery in hearts exposed
to high levels of circulating fatty acids, but reperfused with
glucose only. Thus, it is possible that in the current study,
MPC promoted improved hemodynamic recovery by increasing
glucose metabolism, and thereby inhibiting oxidation of residual
fatty acids during early reperfusion. Indeed, stimulation of
glucose metabolism and inhibition of fatty acids during early
reperfusion is associated with better hemodynamic recovery
(Lopaschuk et al., 2003; Ussher et al., 2012). Importantly, the
effects of energy substrate metabolism on MPC may contribute
to variable cardioprotective benefits in clinical trials (Hausenloy
and Yellon, 2016) and have not been thoroughly investigated.
We are currently evaluating metabolic changes induced by
MPC to further characterize this concept. Importantly, Ferrera
et al. (2015) recently reported improvements in hemodynamic
recovery with MPC and low-pressure reperfusion in an unloaded
isolated heart model. Of particular interest, low-pressure
reperfusion resulted in higher post-ischemic recovery compared
to MPC when it was applied after 3 min of reperfusion. Thus,
low-pressure reperfusion represents an additional, promising
strategy to improve post-ischemic cardiac recovery in DCD
hearts.
Cardioprotection provided byMPC is believed to be mediated
by a combination of passive effects (slowing the normalization
of intracellular homeostasis) and active effects (recruitment
of pro-survival intracellular signaling pathways [reperfusion
injury salvage kinase (RISK) and survivor activating factor
enhancement (SAFE) (Tsang et al., 2004; Bopassa et al., 2006;
Lacerda et al., 2009)], opening of mitochondrial ATP-dependent
potassium channel (Garlid et al., 2009), and inhibition of
mPTP opening (Hausenloy et al., 2002; Argaud et al., 2005).
Given that MPC has previously been demonstrated to improve
mitochondrial function (Bopassa et al., 2005, 2006), one might
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FIGURE 2 | Post-ischemic hemodynamic function. (A) LV work (left ventricular work: HR*DP); (B) DP (developed pressure); (C) dP/dtmax (maximum first
derivative of LV pressure); (D) dP/dtmin (minimum first derivative of LV pressure); (E) CO (cardiac output); (F): CF (coronary flow). CT, control; HY, hypoxia; MH, mild
hypothermia; MPC, mechanical postconditioning; PH, acidic. Percentage of recovery corresponds to the value at 60min reperfusion expressed as a percentage of the
mean pre-ischemic values. Data are expressed as mean ± SD. *MH vs. control, p < 0.05; †MPC vs. control, p < 0.05; ‡HY vs. control, p < 0.05. n = (8–10)
expect lower cyt c release at reperfusion following MPC.
However, cyt c release at reperfusion was not different with
MPC compared with controls, while it was significantly greater
at baseline. It is possible that a lower cyt c release could have
been measured at reperfusion, if no differences in cyt c release
had been measured at baseline. In contrast, we demonstrate
that MPC significantly improved oxygen consumption compared
with controls, implying a better metabolic recovery, as would
be expected with preserved mitochondrial integrity. In addition,
we demonstrate that MPC induced a greater coronary flow
during reperfusion compared with controls suggesting improved
endothelial function.
In our model, brief hypoxic reperfusion performed
immediately after ischemia improved hemodynamic function
(LV work, developed pressure, contraction rate, relaxation rate,
and coronary flow) compared with oxygenated reperfusion
(controls). This is in agreement with Serviddio et al. (2005) who
reported that the LV developed pressure was improved after a
short period of hypoxia at the onset of reperfusion, although
this study was performed under different and potentially
less severe ischemic conditions; hearts were cooled (4◦C)
and protected with a cardioplegic solution. A brief period of
hypoxia at the onset of reperfusion should benefit the heart by
delaying the reoxygenation of the ischemic myocardium and
thereby reducing reactive oxygen species production and the
damaging effects of oxidative stress, which include disruption
of mitochondrial integrity (Serviddio et al., 2005; Yellon
and Hausenloy, 2007; Thu et al., 2010). Correspondingly, we
observed a tendency toward reduced cyt c release at reperfusion,
suggesting less mitochondrial damage compared to controls.
We also measured higher coronary flow at the beginning of
reperfusion, suggesting improved endothelial function. Further,
several studies have also demonstrated beneficial effects of a brief
period of hypoxic reperfusion after ischemia (Serviddio et al.,
2005; Sun et al., 2005; Angelos et al., 2006). These studies were
performed using either Langendorff-perfused hearts or cells,
and therefore, lack information concerning the pump function
of the heart. Moreover, these experimental models were not
specifically designed for DCD, either having a cold ischemia
and/or not using clinically relevant energy substrates (high levels
of circulating fatty acids in the pre-ischemic period).
We also evaluated the possible benefit of an initial brief
period ofmildly acidic reperfusion. Although it has been reported
to improve hemodynamic recovery (Inserte et al., 2008, 2011;
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FIGURE 3 | Metabolic parameters. (A), Oxygen (O2) consumption; (B),
Cytochrome c release; (C), Lactate accumulation. CT, control; HY, hypoxia;
MH, mild hypothermia; MPC, mechanical postconditioning; PH, acidic.
Percentage of recovery corresponds to the value at 60min reperfusion
expressed as a percentage of the mean pre-ischemic value. Data are
expressed as mean ± SD. *MH vs. control, p < 0.05; †MPC vs. control, p <
0.05; ‡HY vs. control, p < 0.05; §PH vs. control, p < 0.05. n = (5–10)
Duan et al., 2011; Penna et al., 2013; White et al., 2016),
infarct size (Inserte et al., 2008; Penna et al., 2013), ATP
levels (Inserte et al., 2008), and to decrease cyt c release and
mitochondrial swelling (Duan et al., 2011) and markers of cell
death (Inserte et al., 2008; Duan et al., 2011), we did not
observe hemodynamic benefits, nor did we see a difference,
compared to controls, in necrosis parameters. Although we
measured higher oxygen consumption at 10min reperfusion,
we did not see other differences in metabolic recovery. Mildly
acid reperfusion is believed to act by delaying the restoration of
physiological pH (Inserte et al., 2008, 2011), thereby prolonging
the low-pH–induced inhibition of mPTP opening while reducing
intracellular calcium overload and hypercontracture in the first
minutes of reperfusion. Discrepant cardioprotective effects for
mildly acidic reperfusion between previous studies (Inserte et al.,
2008; Duan et al., 2011; Inserte et al., 2011; Penna et al.,
2013; White et al., 2016) and ours are unlikely to be explained
by differences in the acidic reperfusion conditions (previous
studies used pH ranging from 6.4 to 6.8 for 2–3min, while we
used pH 6.8 for 3min), but may be explained by differences
FIGURE 4 | Necrosis markers. (A), LDH (lactate dehydrogenase) release;
(B), TnT (Troponin T) release. CT, control; HY, hypoxia; MH, mild hypothermia;
MPC, mechanical postconditioning; PH, acidic. Data are expressed as mean
± SD. *MH vs. control, p < 0.05; †MPC vs. control, p < 0.05; ‡HY vs. control,
p < 0.05. n = (6–10)
in experimental conditions, as several previous studies used
longer ischemic periods [30–40min vs. 27min in our study;
(Inserte et al., 2008, 2011; Duan et al., 2011; Penna et al.,
2013)] and/or higher buffer calcium concentrations 1.4–1.8mM
(Inserte et al., 2008, 2011; Duan et al., 2011) or lower (0.22
mmol/L) (White et al., 2016) vs. 1.25mM in our study. Taken
together, conditions in several previous reports are likely to
generate a more severe ischemia than in our study, which may
lead to conditions that are more damaging, but put hearts in
a position to benefit from mildly acidic reperfusion. Moreover,
combined conditions such as a hypocalcemic, acidic solution
(White et al., 2016) might be more effective in improving post-
ischemic recovery than a normocalcemic, acidic solution, as used
in our study.
Markers of cell death, release of LDH and TnT into the
coronary eﬄuent, were monitored to provide insight into
the mechanisms underlying the cardioprotective effects of
reperfusion strategies. Similar patterns for LDH and TnT
release were expected, and generally observed for baseline
and 60min reperfusion time points; at 60min reperfusion
LDH and TnT tended to be lower for MPC and hypoxia
compared to controls, suggesting less cell death with these
two strategies. However, TnT, but not LDH, release at 10min
reperfusion was significantly higher in the MPC group vs.
controls (p < 0.05). The reason for this discrepancy is not
immediately obvious. It is worth noting that assessments of
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LDH and TnT were performed at 10 and 60min reperfusion;
early time points compared with clinical measurements which
are typically performed at hours or days after an ischemic
insult. Nonetheless, useful information can be gained from
these early time points; we have previously demonstrated that
release of LDH, but not TnT, at 10min reperfusion is an early
predictive parameter of subsequent hemodynamic recovery in
an isolated rat heart model of DCD (Sourdon et al., 2013).
Therefore, the timing of release of LDH and TnT is likely
not identical during early reperfusion, and LDH at 10min
reperfusion may provide a better indicator of recovery than
TnT.
Limitations
Our findings support the concept that controlled reperfusion
strategies may be useful to optimize post-ischemic function
in heart grafts obtained with DCD; nonetheless, several
limitations exist. First, the anesthetics used in this study are
ketamine and xylazine, which have been shown to interfere
with the sympathetic nervous system (Juang et al., 1980;
Svorc et al., 2013) and could have a possible confounding
effect on ischemia reperfusion injury. Nonetheless, we
expect to have similar effects of the anesthetics in all the
experimental groups. In addition, these results were obtained
in an isolated rat heart model and are as such not fully
representative of a clinical scenario. Indeed, extrapolation of
results obtained in animal experiments to clinical scenarios
certainly depends on the species being evaluated (Rossello
and Yellon, 2016) and differences in animal physiology,
including species-specific sensitivity to myocardial ischemia
reperfusion (Lecour et al., 2014). As a consequence, additional
preclinical testing is required, including evaluations in a
larger animal model. Finally, maintenance of post-ischemic
benefits obtained with these strategies applied at the onset
of reperfusion must be confirmed following storage and
transplantation.
Conclusion
In the current study, we demonstrate that improving the
heart function after normothermic, global ischemia is possible
through various controlled reperfusion strategies including
mild hypothermia, mechanical postconditioning and hypoxia.
Differing underlying mechanisms seem to be involved. Thus,
a combination of these strategies might be necessary to
achieve further improvement in post-ischemic function and
may also provide a more robust strategy that could be of
use in the establishment of clinical protocols for DCD heart
transplantation.
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